Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease
Author(s): Chandy D | Aronow WS | Banach M
Volume: 2013
Issue: default
Year: 2013
Author(s): Chandy D | Aronow WS | Banach M Volume: 2013 Issue: default Year: 2013
Prevalence of hypertension and its risk factors in southwest Ethiopia: a hospital-based cross-sectional survey
Author(s): Gudina EK | Michael Y | Assegid S
Volume: 2013
Issue: default
Year: 2013
Author(s): Gudina EK | Michael Y | Assegid S Volume: 2013 Issue: default Year: 2013
Long-acting nifedipine for hypertensive patients in the Middle East and Morocco: observations on efficacy and tolerability of monotherapy or combination therapy
Author(s): Ghoneim RA | Omar AK | Sebastian VJ | Kassab R | Akijian G | Hafiz M | Schmidt B
Volume: 2013
Issue: default
Year: 2013
Author(s): Ghoneim RA | Omar AK | Sebastian VJ | Kassab R | Akijian G | Hafiz M | Schmidt B Volume: 2013 Issue: default Year: 2013
Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trial
Author(s): Zhu D | Bays H | Gao P | Mattheus M | Voelker B | Ruilope LM
Volume: 2013
Issue: default
Year: 2013
Author(s): Zhu D | Bays H | Gao P | Mattheus M | Voelker B | Ruilope LM Volume: 2013 Issue: default Year: 2013
Cardio-ankle vascular index (CAVI) as an indicator of arterial stiffness
Author(s): Sun CK
Volume: 2013
Issue: default
Year: 2013
Author(s): Sun CK Volume: 2013 Issue: default Year: 2013
Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination
Author(s): Hovater MB | Jaimes EA
Volume: 2013
Issue: default
Year: 2013
Author(s): Hovater MB | Jaimes EA Volume: 2013 Issue: default Year: 2013
A review of the gastrointestinal therapeutic system (GITS) formulation and its effectiveness in the delivery of antihypertensive drug treatment (focus on nifedipine GITS)
Author(s): Meredith PA | Elliott HL
Volume: 2013
Issue: default
Year: 2013
Author(s): Meredith PA | Elliott HL Volume: 2013 Issue: default Year: 2013
Treating resistant hypertension: role of renal denervation
Author(s): Urban D | Ewen S | Ukena C | Linz D | Böhm M | Mahfoud F
Volume: 2013
Issue: default
Year: 2013
Author(s): Urban D | Ewen S | Ukena C | Linz D | Böhm M | Mahfoud F Volume: 2013 Issue: default Year: 2013
Azilsartan/chlorthalidone combination therapy for blood pressure control
Author(s): Cheng JW
Volume: 2013
Issue: default
Year: 2013
Author(s): Cheng JW Volume: 2013 Issue: default Year: 2013
The TRINITY Study: distribution of systolic blood pressure reductions
Author(s): Sugimoto DH | Chrysant SG | Melino M | Lee J | Fernandez V | Heyrman R
Volume: 2013
Issue: default
Year: 2013
Author(s): Sugimoto DH | Chrysant SG | Melino M | Lee J | Fernandez V | Heyrman R Volume: 2013 Issue: default Year: 2013
Current perspectives on rosuvastatin
Author(s): Hu M | Tomlinson B
Volume: 2013
Issue: default
Year: 2013
Author(s): Hu M | Tomlinson B Volume: 2013 Issue: default Year: 2013
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
Author(s): Funder JW
Volume: 2013
Issue: default
Year: 2013
Author(s): Funder JW Volume: 2013 Issue: default Year: 2013
Current perspectives on combination therapy in the management of hypertension
Author(s): Mallat SG | Itani HS | Tanios BY
Volume: 2013
Issue: default
Year: 2013
Author(s): Mallat SG | Itani HS | Tanios BY Volume: 2013 Issue: default Year: 2013
Management of patients with resistant hypertension: current treatment options
Author(s): Kumar N | Calhoun DA | Dudenbostel T
Volume: 2013
Issue: default
Year: 2013
Author(s): Kumar N | Calhoun DA | Dudenbostel T Volume: 2013 Issue: default Year: 2013
Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials
Author(s): Lemoine P | Wade AG | Katz A | Nir T | Zisapel N
Volume: 2012
Issue: default
Year: 2012
Author(s): Lemoine P | Wade AG | Katz A | Nir T | Zisapel N Volume: 2012 Issue: default Year: 2012
Cardio classics revisited: focus on the role of amlodipine
Author(s): Owen AJ | Reid CM
Volume: 2012
Issue: default
Year: 2012
Author(s): Owen AJ | Reid CM Volume: 2012 Issue: default Year: 2012
Out-of-office blood pressure: from measurement to control
Author(s): Baguet JP
Volume: 2012
Issue: default
Year: 2012
Author(s): Baguet JP Volume: 2012 Issue: default Year: 2012
Long-term use and tolerability of irbesartan for control of hypertension
Author(s): Forni V | Wuerzner G | Pruijm M | Burnier M
Volume: 2011
Issue: default
Year: 2011
Author(s): Forni V | Wuerzner G | Pruijm M | Burnier M Volume: 2011 Issue: default Year: 2011
Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension
Author(s): Segura J | Ruilope LM
Volume: 2011
Issue: default
Year: 2011
Author(s): Segura J | Ruilope LM Volume: 2011 Issue: default Year: 2011
Short- and long-term physiologic and pharmacologic control of blood pressure in pediatric patients
Author(s): Trachtman H
Volume: 2011
Issue: default
Year: 2011
Author(s): Trachtman H Volume: 2011 Issue: default Year: 2011
A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals
Author(s): Cheryl L Laffer | Fernando Elijovich
Volume: 2011
Issue: default
Year: 2011
Author(s): Cheryl L Laffer | Fernando Elijovich Volume: 2011 Issue: default Year: 2011
Challenges posed to the maternal circulation by pregnancy
Author(s): Valdés G | Corthorn J
Volume: 2011
Issue: default
Year: 2011
Author(s): Valdés G | Corthorn J Volume: 2011 Issue: default Year: 2011
Combining antihypertensive and antihyperlipidemic agents – optimizing cardiovascular risk factor management
Author(s): Zamorano J | Edwards J
Volume: 2011
Issue: default
Year: 2011
Author(s): Zamorano J | Edwards J Volume: 2011 Issue: default Year: 2011
Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination
Author(s): Punzi HA
Volume: 2011
Issue: default
Year: 2011
Author(s): Punzi HA Volume: 2011 Issue: default Year: 2011
Hypertension and other morbidities with Cushing’s syndrome associated with corticosteroids: a review
Author(s): Melpomeni Peppa | Maria Krania | Sotirios A Raptis
Volume: 2011
Issue: default
Year: 2011
Author(s): Melpomeni Peppa | Maria Krania | Sotirios A Raptis Volume: 2011 Issue: default Year: 2011
Evidence-based approach for managing hypertension in type 2 diabetes
Author(s): Gerti Tashko | Robert A Gabbay
Volume: 2010
Issue: default
Year: 2010
Author(s): Gerti Tashko | Robert A Gabbay Volume: 2010 Issue: default Year: 2010
Renoprotection, renin inhibition, and blood pressure control: the impact of aliskiren on integrated blood pressure control
Author(s): Haroon-Ur Rashid
Volume: 2010
Issue: default
Year: 2010
Author(s): Haroon-Ur Rashid Volume: 2010 Issue: default Year: 2010
Intravenous clevidipine for management of hypertension
Author(s): Alma Rivera | Elsa Montoya | Joseph Varon
Volume: 2010
Issue: default
Year: 2010
Author(s): Alma Rivera | Elsa Montoya | Joseph Varon Volume: 2010 Issue: default Year: 2010
Impact of telmisartan in modifying vascular risk
Author(s): Jean-Philippe Baguet | Olivier Ormezzano | Gilles Barone-Rochette
Volume: 2010
Issue: default
Year: 2010
Author(s): Jean-Philippe Baguet | Olivier Ormezzano | Gilles Barone-Rochette Volume: 2010 Issue: default Year: 2010
Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals
Author(s): Jan Basile
Volume: 2010
Issue: default
Year: 2010
Author(s): Jan Basile Volume: 2010 Issue: default Year: 2010
Critical appraisal and pooled analysis of telmisartan alone or in combination with hydrochlorothiazide for achieving blood pressure goals
Author(s): Satoshi Morimoto | Nobuyuki Takahashi | Tatsuyori Morita | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Satoshi Morimoto | Nobuyuki Takahashi | Tatsuyori Morita | et al Volume: 2010 Issue: default Year: 2010
De-stiffening drug therapy and blood pressure control
Author(s): Michel E Safar
Volume: 2010
Issue: default
Year: 2010
Author(s): Michel E Safar Volume: 2010 Issue: default Year: 2010
Update on the role of candesartan in the optimal management of hypertension and cardiovascular risk reduction
Author(s): Ikechi G Okpechi | Brian L Rayner
Volume: 2010
Issue: default
Year: 2010
Author(s): Ikechi G Okpechi | Brian L Rayner Volume: 2010 Issue: default Year: 2010
Safety and tolerability of fixed antihypertensive combinations in blood pressure control: focus on olmesartan medoxomil and amlodipine combination
Author(s): Ijlal Uddin | Shakil Aslam
Volume: 2010
Issue: default
Year: 2010
Author(s): Ijlal Uddin | Shakil Aslam Volume: 2010 Issue: default Year: 2010
Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination
Author(s): Giuseppe Derosa | Sibilla AT Salvadeo
Volume: 2010
Issue: default
Year: 2010
Author(s): Giuseppe Derosa | Sibilla AT Salvadeo Volume: 2010 Issue: default Year: 2010
Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes
Author(s): Eduardo Pimenta | Suzanne Oparil
Volume: 2010
Issue: default
Year: 2010
Author(s): Eduardo Pimenta | Suzanne Oparil Volume: 2010 Issue: default Year: 2010
Is tetrahydrobiopterin a therapeutic option in diabetic hypertensive patients?
Author(s): Alberto Francisco Rubio-Guerra | Hilda Vargas-Robles | Luz Maria Ramos-Brizuela | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Alberto Francisco Rubio-Guerra | Hilda Vargas-Robles | Luz Maria Ramos-Brizuela | et al Volume: 2010 Issue: default Year: 2010
Fixed combinations in the pragmatic management of hypertension: focus on aliskiren and hydrochlorothiazide as a single pill
Author(s): Michel Burnier
Volume: 2010
Issue: default
Year: 2010
Author(s): Michel Burnier Volume: 2010 Issue: default Year: 2010
Optimal management of hypertension in elderly patients
Author(s): Maria Czarina Acelajado
Volume: 2010
Issue: default
Year: 2010
Author(s): Maria Czarina Acelajado Volume: 2010 Issue: default Year: 2010
Critical appraisal of the differential effects of antihypertensive agents on arterial stiffness
Author(s): Francesca Kum | Janaka Karalliedde
Volume: 2010
Issue: default
Year: 2010
Author(s): Francesca Kum | Janaka Karalliedde Volume: 2010 Issue: default Year: 2010
Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension – update on clinical utility
Author(s): Vivencio Barrios | Carlos Escobar
Volume: 2010
Issue: default
Year: 2010
Author(s): Vivencio Barrios | Carlos Escobar Volume: 2010 Issue: default Year: 2010
Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials
Author(s): Cesare Cuspidi | Francesca Negri | Valentina Giudici | Anna Capra | et al.
Volume: 2009
Issue: default
Year: 2009
Author(s): Cesare Cuspidi | Francesca Negri | Valentina Giudici | Anna Capra | et al. Volume: 2009 Issue: default Year: 2009
Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors
Author(s): Alberto F Rubio-Guerra | David Castro-Serna | Cesar I Elizalde Barrera | et al
Volume: 2009
Issue: default
Year: 2009
Author(s): Alberto F Rubio-Guerra | David Castro-Serna | Cesar I Elizalde Barrera | et al Volume: 2009 Issue: default Year: 2009
Valsartan combination therapy in the management of hypertension – patient perspectives and clinical utility
Author(s): David T Nash | Michael S McNamara
Volume: 2009
Issue: default
Year: 2009
Author(s): David T Nash | Michael S McNamara Volume: 2009 Issue: default Year: 2009
Can nocturnal hypertension predict cardiovascular risk?
Author(s): Oded Friedman | Alexander G Logan
Volume: 2009
Issue: default
Year: 2009
Author(s): Oded Friedman | Alexander G Logan Volume: 2009 Issue: default Year: 2009
Clinical approach in treatment of resistant hypertension
Author(s): Jennifer Frank | David Sommerfeld
Volume: 2009
Issue: default
Year: 2009
Author(s): Jennifer Frank | David Sommerfeld Volume: 2009 Issue: default Year: 2009
Antihypertensive effects of astaxanthin
Author(s): Hidekatsu Yanai | Kumie Ito | Hiroshi Yoshida | Norio Tada
Volume: 2008
Issue: default
Year: 2008
Author(s): Hidekatsu Yanai | Kumie Ito | Hiroshi Yoshida | Norio Tada Volume: 2008 Issue: default Year: 2008
Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study
Author(s): Giray Kabakci | Nevres Koylan | Baris Ilerigelen | Omer Kozan | Kemalettin Buyukozturk on behalf of the ICEBERG Investigators
Volume: 2008
Issue: default
Year: 2008
Author(s): Giray Kabakci | Nevres Koylan | Baris Ilerigelen | Omer Kozan | Kemalettin Buyukozturk on behalf of the ICEBERG Investigators Volume: 2008 Issue: default Year: 2008
Cuff inflation during ambulatory blood pressure monitoring and heart rate
Author(s): Mia Skov-Madsen | My Svensson | Jeppe Hagstrup Christensen
Volume: 2008
Issue: default
Year: 2008
Author(s): Mia Skov-Madsen | My Svensson | Jeppe Hagstrup Christensen Volume: 2008 Issue: default Year: 2008